Suppr超能文献

革兰氏阳性菌的抗菌肽耐药机制。

Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.

机构信息

Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Rd, Atlanta, GA 30322, USA;

出版信息

Antibiotics (Basel). 2014 Oct 13;3(4):461-92. doi: 10.3390/antibiotics3040461.

Abstract

Antimicrobial peptides, or AMPs, play a significant role in many environments as a tool to remove competing organisms. In response, many bacteria have evolved mechanisms to resist these peptides and prevent AMP-mediated killing. The development of AMP resistance mechanisms is driven by direct competition between bacterial species, as well as host and pathogen interactions. Akin to the number of different AMPs found in nature, resistance mechanisms that have evolved are just as varied and may confer broad-range resistance or specific resistance to AMPs. Specific mechanisms of AMP resistance prevent AMP-mediated killing against a single type of AMP, while broad resistance mechanisms often lead to a global change in the bacterial cell surface and protect the bacterium from a large group of AMPs that have similar characteristics. AMP resistance mechanisms can be found in many species of bacteria and can provide a competitive edge against other bacterial species or a host immune response. Gram-positive bacteria are one of the largest AMP producing groups, but characterization of Gram-positive AMP resistance mechanisms lags behind that of Gram-negative species. In this review we present a summary of the AMP resistance mechanisms that have been identified and characterized in Gram-positive bacteria. Understanding the mechanisms of AMP resistance in Gram-positive species can provide guidelines in developing and applying AMPs as therapeutics, and offer insight into the role of resistance in bacterial pathogenesis.

摘要

抗菌肽(AMPs)在许多环境中作为去除竞争生物体的工具发挥着重要作用。作为回应,许多细菌已经进化出抵抗这些肽并防止 AMP 介导的杀伤的机制。AMP 耐药机制的发展是由细菌物种之间的直接竞争以及宿主和病原体相互作用驱动的。与自然界中发现的不同 AMP 数量一样,进化而来的耐药机制也多种多样,可能赋予 AMP 广谱耐药或特定耐药性。AMP 耐药的具体机制可防止 AMP 介导的对单一类型 AMP 的杀伤,而广泛的耐药机制通常会导致细菌细胞表面的整体变化,并保护细菌免受具有相似特性的一大类 AMP 的侵害。AMP 耐药机制存在于许多细菌物种中,可以为其提供与其他细菌物种或宿主免疫反应竞争的优势。革兰氏阳性菌是最大的 AMP 产生群体之一,但革兰氏阳性菌 AMP 耐药机制的表征落后于革兰氏阴性菌。在这篇综述中,我们总结了已在革兰氏阳性菌中鉴定和表征的 AMP 耐药机制。了解革兰氏阳性菌中 AMP 耐药机制可以为开发和应用 AMP 作为治疗药物提供指导,并深入了解耐药性在细菌发病机制中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验